Targeting immunosenescence for improved tumor immunotherapy.

Area of Science:

• Oncology
• Immunology
• Gerontology

Background:

• Tumor immunotherapy has advanced cancer treatment.
• Immunosenescence, or age-related immune decline, impairs anti-tumor responses.
• This decline increases cancer vulnerability and affects treatment efficacy.

Purpose of the Study:

• To elucidate the molecular mechanisms and hallmarks of immunosenescence.
• To explore the role of immunosenescence in tumorigenesis and the tumor immune microenvironment (TIME).
• To evaluate current and emerging therapeutic strategies for combating immunosenescence in cancer immunotherapy.

Main Methods:

• Review of molecular, cellular, organ, and disease-level alterations in immunosenescence.
• Analysis of senescence-related extracellular matrix (ECM) contributions.
• Evaluation of treatment strategies targeting immunosenescence hallmarks and immune restoration.

Main Results:

• Immunosenescence involves complex molecular and cellular changes impacting the immune system.
• Senescence-related ECM modifications can influence tumor progression.
• Targeting immunosenescence offers potential for improved cancer immunotherapy.

Conclusions:

• Understanding immunosenescence is crucial for developing effective cancer immunotherapies.
• Restoring immune function in aging individuals can enhance anti-tumor immunity.
• Future strategies aim to prevent tumor development, recurrence, and metastasis by addressing immunosenescence.